CVRx, Inc.
CVRX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001235912
No open-market purchases or sales by CVRx, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $78.7M in total; no superinvestor holds it.
Holders of 5% or more of CVRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CVRx, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 13G/A | 15.40%4.02M shares | – | Feb 7, 20224 filings | Jan 12, 2026 | SEC |
| New Enterprise Associates 10 L P | 13D/A | 7.80%2.03M shares | – | Jul 15, 20213 filings | Feb 20, 2025 | SEC |
| Vensana Capital I GP, LLC | 13G/A | 7.20%1.76M shares | – | Feb 10, 20224 filings | Feb 6, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on CVRx, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 2, 20269:30 PM ET | Chernett Jorey | 13D/A | 0.62%165.0K shares | −4.88 ppfrom 5.50%Below 5% | Sep 30, 2026 | SEC |
| Aug 24, 20268:00 PM ET | Chernett Jorey | 13D | 5.50%1.46M shares | 0.00 ppfrom 5.50% | Aug 24, 2026 | SEC |
| Aug 14, 20262:38 PM ET | Chernett Jorey | 13G | 5.50%1.46M shares | New | Aug 7, 2026 | SEC |
| Jan 12, 20267:51 PM ET | Johnson & Johnsonand 1 other | 13G/A | 15.40%4.02M shares | – | Dec 31, 2025 | SEC |
| Feb 20, 20257:08 PM ET | New Enterprise Associates 10 L Pand 7 others | 13D/A | 7.80%2.03M shares | – | Feb 18, 2025 | SEC |
| Feb 6, 20256:49 PM ET | Cooperatieve Gilde Healthcare IV U.A.and 4 others | 13D/A | 4.90%1.23M shares | –Below 5% | Feb 4, 2025 | SEC |
| Feb 6, 20254:46 PM ET | Vensana Capital I GP, LLCand 3 others | 13G/A | 7.20%1.76M shares | – | Dec 31, 2024 | SEC |
| Nov 7, 2024 | New Enterprise Associates 10 L P | 13D/AOld format | – | – | – | SEC |
| Nov 1, 2024 | Johnson & Johnson | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2024 | Vensana Capital I GP, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2024 | Johnson & Johnson | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2024 | Cooperatieve Gilde Healthcare IV U.A. | 13D/AOld format | – | – | – | SEC |
| Dec 29, 2023 | Cooperatieve Gilde Healthcare IV U.A. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Soleus Capital Master Fund, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | GSK plc | 13GOld format | – | – | – | SEC |
| Feb 3, 2023 | Vensana Capital I GP, LLC | 13G/AOld format | – | – | – | SEC |
| Apr 29, 2022 | Soleus Capital Master Fund, L.P. | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | Vensana Capital I GP, LLC | 13GOld format | – | New | – | SEC |
| Feb 7, 2022 | Johnson & Johnson | 13GOld format | – | New | – | SEC |
| Jul 15, 2021 | New Enterprise Associates 10 L P | 13DOld format | – | New | – | SEC |
| Jul 12, 2021 | GSK plc | 13GOld format | – | New | – | SEC |
| Jul 12, 2021 | Cooperatieve Gilde Healthcare IV U.A. | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
13 notices from officers, directors and other affiliates planning to sell CVRx, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 29, 20242:19 PM ET | Behbahani AliOfficer | 21.8K | $334.1K | Nov 29, 2024 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES | SEC |
| Nov 19, 20244:27 PM ET | Paul VerrastroOfficer | 1.43K | $19.4K | Nov 19, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 18, 20244:34 PM ET | Behbahani AliOfficer | 9 | $126.59 | Nov 18, 2024 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES | SEC |
| Nov 5, 20245:36 PM ET | New Enterprise Associates VIII, LPAffiliate | 171.1K | $2.57M | Nov 5, 2024 | J.P. Morgan Securities LLC | SEC |
| Nov 5, 20245:35 PM ET | NEA Enterprise Associates 8A, LPAffiliate | 173.4K | $2.61M | Nov 5, 2024 | J.P. Morgan Securities LLC | SEC |
| Jul 26, 20245:48 PM ET | Palmer Craig E.Officer | 18.2K | $175.1K | Jul 26, 2024 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES | SEC |
| Jul 25, 20246:24 PM ET | Palmer Craig E.Officer | 11.9K | $113.9K | Jul 25, 2024 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES | SEC |
| Jul 24, 20245:43 PM ET | Palmer Craig E.Officer | 2.00K | $19.2K | Jul 24, 2024 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES | SEC |
| Jul 23, 20245:49 PM ET | Palmer Craig E.Officer | 2.00K | $20.1K | Jul 23, 2024 | Morgan Stanley Smith Barney LLC Executive Services | SEC |
| Jul 22, 20245:35 PM ET | Palmer Craig E.Officer | 3.93K | $37.7K | Jul 22, 2024 | MORGAN STANLEY SMITH BARNEY, LLC. EXECUTIVE SERVICES | SEC |
| Jul 16, 20245:33 PM ET | Palmer Craig E.Officer | 7.15K | $70.5K | Jul 16, 2024 | Morgan Stanley Smith Barney LLC Executive Services | SEC |
| Feb 20, 20244:42 PM ET | Paul VerrastroOfficer | 2.54K | $55.7K | Feb 20, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 10, 20236:11 PM ET | Nehra John MDirector | 10.6K | $182.7K | Aug 10, 2023 | ETRADE FINANCIAL CORPORATION | SEC |